1. Apomorphine with domperidone: minimising cardiac effects

   News item 30 April 2016 Pages: 1 - 1

2. FDA issues warnings for Pharmakon's sterile drug products

   News item 30 April 2016 Pages: 2 - 2

3. Lareb: fixed drug eruptions to be added to doxycycline labelling

   News item 30 April 2016 Pages: 3 - 3

4. MHRA: avoid live attenuated vaccines in immunosuppressed

   News item 30 April 2016 Pages: 4 - 4

5. PRAC public hearing procedure rules finalised

   News item 30 April 2016 Pages: 5 - 5

6. Popular OTC antihistamines worsen restless legs syndrome

   News item 30 April 2016 Pages: 6 - 6

7. Antimicrobials associated with meningitis

   Clinical study 30 April 2016 Pages: 7 - 7

8. Brain effects of anticholinergic medication

   Clinical study 30 April 2016 Pages: 8 - 8

9. Comparable CVD risks with GLP-1 agonists vs other antidiabetics

   Clinical study 30 April 2016 Pages: 9 - 9

10. Ondansetron: low risk of birth defects

    Clinical study 30 April 2016 Pages: 10 - 10

11. Proton pump inhibitors associated with serious renal outcomes

    Clinical study 30 April 2016 Pages: 11 - 11

12. Aciclovir

    Case report 30 April 2016 Pages: 12 - 12

13. Acitretin

    Case report 30 April 2016 Pages: 13 - 13

14. Aclarubicin/cytarabine/granulocyte colony stimulating factors

    Case report 30 April 2016 Pages: 14 - 14

15. Adalimumab

    Case report 30 April 2016 Pages: 15 - 15

16. Adalimumab

    Case report 30 April 2016 Pages: 16 - 16

17. Adalimumab/etanercept/infliximab

    Case report 30 April 2016 Pages: 17 - 17

18. Adenosine

    Case report 30 April 2016 Pages: 18 - 18

19. Amiodarone

    Case report 30 April 2016 Pages: 19 - 19

20. Amitriptyline

    Case report 30 April 2016 Pages: 20 - 20

21. Amitriptyline overdose

    Case report 30 April 2016 Pages: 21 - 21

22. Amoxicillin/clavulanic acid

    Case report 30 April 2016 Pages: 22 - 22

23. Anticancers

    Case report 30 April 2016 Pages: 23 - 23

24. Antineoplastics

    Case report 30 April 2016 Pages: 24 - 24

25. Antineoplastics

    Case report 30 April 2016 Pages: 25 - 25

26. Antineoplastics

    Case report 30 April 2016 Pages: 26 - 26

27. Antineoplastics

    Case report 30 April 2016 Pages: 27 - 27

28. Apixaban/clopidogrel

    Case report 30 April 2016 Pages: 28 - 28

29. Aspirin

    Case report 30 April 2016 Pages: 29 - 29

30. Aspirin

    Case report 30 April 2016 Pages: 30 - 30

31. Aspirin/heparin

    Case report 30 April 2016 Pages: 31 - 31

32. Atorvastatin

    Case report 30 April 2016 Pages: 32 - 32

33. Azathioprine

    Case report 30 April 2016 Pages: 33 - 33

34. Baclofen

    Case report 30 April 2016 Pages: 34 - 34

35. BCG

    Case report 30 April 2016 Pages: 35 - 35

36. BCG vaccine

    Case report 30 April 2016 Pages: 36 - 36

37. Benzonatate overdose

    Case report 30 April 2016 Pages: 37 - 37

38. Bevacizumab/erlotinib

    Case report 30 April 2016 Pages: 38 - 38

39. Bortezomib/lenalidomide

    Case report 30 April 2016 Pages: 39 - 39

40. Brincidofovir

    Case report 30 April 2016 Pages: 40 - 40

41. Busulfan/melphalan

    Case report 30 April 2016 Pages: 41 - 41

42. Capecitabine

    Case report 30 April 2016 Pages: 42 - 42

43. Capecitabine/epirubicin/oxaliplatin

    Case report 30 April 2016 Pages: 43 - 43

44. Carmustine

    Case report 30 April 2016 Pages: 44 - 44

45. Caspofungin

    Case report 30 April 2016 Pages: 45 - 45

46. Certolizumab pegol

    Case report 30 April 2016 Pages: 46 - 46

47. Cetuximab

    Case report 30 April 2016 Pages: 47 - 47

48. Cetuximab

    Case report 30 April 2016 Pages: 48 - 48

49. Chondroitin sulfate/hyaluronic acid

    Case report 30 April 2016 Pages: 49 - 49

50. Ciclosporin

    Case report 30 April 2016 Pages: 50 - 50